New vaccination strategies in liver cancer

被引：26

作者：

Buonaguro, Luigi ^{[1
]}

机构：

[1] Natl Canc Inst Fond G Pascale, Lab Mol Biol & Viral Oncogenesis, Naples, Italy

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2017年 / 36卷

关键词：

T-CELL RESPONSES; PULSED DENDRITIC CELLS; HEPATOCELLULAR-CARCINOMA PATIENTS; TELOMERASE PEPTIDE VACCINATION; RNA-BASED ADJUVANT; PHASE-I TRIAL; CATALYTIC SUBUNIT; TUMOR LYSATE; OPEN-LABEL; IMMUNOTHERAPY;

D O I：

10.1016/j.cytogfr.2017.06.010

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：125 / 129

页数：5

共 62 条

[1] Hepatocellular carcinoma: a review [J].

Balogh, Julius ;

Victor, David, III ;

Asham, Emad H. ;

Burroughs, Sherilyn Gordon ;

Boktour, Maha ;

Saharia, Ashish ;

Li, Xian ;

Ghobrial, R. Mark ;

Monsour, Howard P., Jr. .

JOURNAL OF HEPATOCELLULAR CARCINOMA, 2016, 3 :41-53

[2] Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma [J].

Bricard, G ;

Bouzourene, H ;

Martinet, O ;

Rimoldi, D ;

Halkic, N ;

Gillet, M ;

Chaubert, P ;

MacDonald, HR ;

Romero, P ;

Cerottini, JC ;

Speiser, DE .

JOURNAL OF IMMUNOLOGY, 2005, 174 (03) :1709-1716

[3] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Bruix, Jordi ;

Qin, Shukui ;

Merle, Philippe ;

Granito, Alessandro ;

Huang, Yi-Hsiang ;

Bodoky, Gyrogy ;

Pracht, Marc ;

Yokosuka, Osamu ;

Rosmorduc, Olivier ;

Breder, Valeriy ;

Gerolami, Rene ;

Masi, Gianluca ;

Ross, Paul J. ;

Song, Tianqiang ;

Bronowicki, Jean-Pierre ;

Ollivier-Hourmand, Isabelle ;

Kudo, Masatoshi ;

Cheng, Ann-Lii ;

Llovet, Josep M. ;

Finn, Richard S. ;

LeBerre, Marie-Aude ;

Baumhauer, Annette ;

Meinhardt, Gerold ;

Han, Guohong .

LANCET, 2017, 389 (10064) :56-66

[4] Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer [J].

Brunsvig, Paal F. ;

Aamdal, Steinar ;

Gjertsen, Marianne K. ;

Kvalheim, Gunnar ;

Markowski-Grimsrud, Carrie J. ;

Sve, Ingunn ;

Dyrhaug, Marianne ;

Trachsel, Sissel ;

Moller, Mona ;

Eriksen, Jon A. ;

Gaudernack, Gustav .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (12) :1553-1564

[5] Developments in cancer vaccines for hepatocellular carcinoma [J].

Buonaguro, Luigi .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (01) :93-99

[6] Challenges in cancer vaccine development for hepatocellular carcinoma [J].

Buonaguro, Luigi ;

Petrizzo, Annacarmen ;

Tagliamonte, Maria ;

Tornesello, Maria Lina ;

Buonaguro, Franco M. .

JOURNAL OF HEPATOLOGY, 2013, 59 (04) :897-903

[7] A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides [J].

Butterfield, LH ;

Ribas, A ;

Dissette, VB ;

Lee, Y ;

Yang, JQ ;

De la Rocha, P ;

Duran, SD ;

Hernandez, J ;

Seja, E ;

Potter, DM ;

McBride, WH ;

Finn, R ;

Glaspy, JA ;

Economou, JS .

CLINICAL CANCER RESEARCH, 2006, 12 (09) :2817-2825

[8]

Butterfield LH, 2003, CLIN CANCER RES, V9, P5902

[9] INDUCTION OF ANTITUMOR CYTOTOXIC T-LYMPHOCYTES IN NORMAL HUMANS USING PRIMARY CULTURES AND SYNTHETIC PEPTIDE EPITOPES [J].

CELIS, E ;

TSAI, V ;

CRIMI, C ;

DEMARS, R ;

WENTWORTH, PA ;

CHESNUT, RW ;

GREY, HM ;

SETTE, A ;

SERRA, HM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2105-2109

[10] Management of Hepatocellular Carcinoma: Beyond Sorafenib [J].

Chan, Stephen L. ;

Mok, Tony ;

Ma, Brigette B. Y. .

CURRENT ONCOLOGY REPORTS, 2012, 14 (03) :257-266

← 1 2 3 4 5 6 7 →